Q4 2025 Enwave Corp Earnings Call Transcript
Key Points
- EnWave Corp (NWVCF) reported a 71% year-over-year increase in Q4 revenues, reaching $6.2 million.
- Net income from continuous operations rose by 58% year over year, amounting to $928,000.
- The company achieved its highest fiscal year revenue of $13.8 million, a 69% improvement year over year.
- Base royalties in Q4 reached $418,000, marking the highest quarterly third-party base royalties ever generated, up 31% year over year.
- EnWave Corp (NWVCF) successfully sold and commissioned multiple REV machines, indicating strong demand and repeat orders from existing partners.
- Total royalties year over year were flat due to a partner opting not to pay an annual exclusivity royalty.
- SG&A expenses, including R&D, increased by 17% in Q4 2025 compared to the previous year.
- The company faces uncertainties in the timing of closing machine sales, which could impact future revenue projections.
- The cannabis market, while showing potential, remains a secondary focus with limited immediate growth prospects.
- The pharmaceutical industry partnership has yet to yield significant commercial results, with ongoing challenges in securing commitments for new drug development using EnWave's technology.
Good morning, and welcome to EnWave Corporation's fourth-quarter 2025 earnings conference call. My name is Melissa and I will be your operator for today's call. Joining us for today's presentation are the company's President and CEO, Brent Charleton; and Dylan Murray, EnWave's CFO.
(Operator Instructions), and the conference is being recorded. (Operator Instructions) Finally, I'd like to remind everyone that this call will be made available for replay via a link in the Investor Relations section of the company's website at www.enwave.net.
Now, I'd like to turn the call over to Enwave's CEO Mr. Brent Charleton. Please go ahead, sir.
Thank you, and a very good morning to everyone who has joined us today for EnWave's Q4 fiscal 2025 quarterly conference call. Q4 yielded outstanding financial results, and I'm very pleased to summarize our performance details today and discuss our business outlook for the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

